0001140361-23-022490.txt : 20230502
0001140361-23-022490.hdr.sgml : 20230502
20230502163036
ACCESSION NUMBER: 0001140361-23-022490
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230430
FILED AS OF DATE: 20230502
DATE AS OF CHANGE: 20230502
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vollins James
CENTRAL INDEX KEY: 0001757833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36183
FILM NUMBER: 23879598
MAIL ADDRESS:
STREET 1: C/O BIODELIVERY SCIENCES INTERNATIONAL
STREET 2: 4131 PARK LAKE AVE SUITE 225
CITY: RALEIGH
STATE: NC
ZIP: 27607
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Eiger BioPharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001305253
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 361004130
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
BUSINESS PHONE: 650-279-9845
MAIL ADDRESS:
STREET 1: 2155 PARK BOULEVARD
CITY: PALO ALTO
STATE: CA
ZIP: 94306
FORMER COMPANY:
FORMER CONFORMED NAME: Celladon Corp
DATE OF NAME CHANGE: 20041005
4
1
form4.xml
X0407
4
2023-04-30
0001305253
Eiger BioPharmaceuticals, Inc.
EIGR
0001757833
Vollins James
C/O EIGER BIOPHARMACEUTICALS, INC.
2155 PARK BLVD.
PALO ALTO
CA
94306
true
General Counsel
false
Stock Option (Right to Buy)
1.03
2023-04-30
4
A
0
120000
0
A
2033-04-29
Common Stock
120000
120000
D
The option vests as to twenty-five percent of the shares upon the one-year anniversary of April 12, 2023, and in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service status as of each such date.
/s/ James Vollins
2023-05-02